Insights

Professional
Practice
Industry
Region
Trending Topics
Location
Type

Sort by:

Firm News 5 results

Firm News | 2 min read | 02.21.25

Crowell & Moring, Planned Parenthood Federation of America, ACLU of Missouri, and ACLU Reproductive Freedom Project Achieve Victory in Reproductive Rights Case in Missouri

Washington – February 21, 2025: Missouri health care providers will be able to resume abortion care after a Jackson County Circuit judge temporarily blocked the Targeted Regulation of Abortion Providers (TRAP) last week. The TRAP restriction, Missouri’s abortion facility licensure requirement, had been left in place in a previous ruling and prevented providers, like Planned Parenthood, from resuming care, despite the state’s voters’ enacting an amendment on November 5, 2024, to enshrine a right to reproductive freedom in the Missouri Constitution. With this ruling, Missouri becomes the first state in the nation to restore abortion access after a total ban.

Firm News | 9 min read | 01.09.23

Crowell & Moring Elects 16 New Partners, Promotes Five to Senior Counsel, and 25 to Counsel

Crowell & Moring elected 16 lawyers to the firm’s partnership, effective January 1, 2023. The firm also promoted five lawyers to the position of senior counsel and 25 associates to the position of counsel.

Firm News | 2 min read | 09.16.21

Crowell & Moring and ACLU of Maryland Achieve Victory in Removal of the Last Confederate Statue on Public Grounds in Maryland

Washington – September 16, 2021: The Talbot County Council has adopted a resolution to remove the last Confederate statue remaining on public grounds in Maryland. This is a change of position for the Council and follows a lawsuit filed by Crowell & Moring and the American Civil Liberties Union of Maryland. The resolution, passed on September 14, 2021 with a 3-2 vote, orders the movement of the Talbot Boys statue from the Easton courthouse to a private park in Virginia “as soon as is practicable.”
...

Client Alerts 13 results

Client Alert | 5 min read | 02.20.26

Trump Administration Pursues MFN Pricing for Prescription Drugs

By the end of 2025, 16 drug manufacturers had voluntarily negotiated and executed agreements to adopt Most Favored Nation (MFN) pricing for certain high-cost drugs. The Trump Administration highlighted the agreements in its “Great Healthcare Plan,” published on January 15, 2026, and communicated the government’s plans to “codify” such deals as a means of “get[ting] Americans the same low prices that people in other countries pay.” The Administration recently leveraged MFN pricing to establish the TrumpRx website, which helps uninsured or cash-paying consumers find drugs at a discounted price. The website reflects the Administration’s stated commitment to provide more lower-cost drugs directly to consumers. Currently, 40 branded medications are available at reduced prices.
...

Client Alert | 4 min read | 02.11.26

Consolidated Appropriations Act Introduces Sweeping Reforms for Pharmacy Benefit Managers

On February 3, 2026, President Trump signed a $1.2 trillion spending deal that, among other points, introduced significant regulatory changes for Medicare Part D plans and PBMs providing services to PDP sponsors in the Medicare Advantage and Medicare Part D programs, and imposed significant new restrictions and transparency requirements on PBMs contracting with private group health plans.
...

Client Alert | 3 min read | 10.21.25

Pivot Point for 340B: HRSA Rebate Model Pilot Program Approaches Launch

The deadline for Department of Health and Human Services (“HHS”) to notify approved manufacturers of acceptance into the 340B Rebate Model Pilot Program has passed, and stakeholders across the healthcare industry should start planning for compliance and operational changes. The Model Pilot Program may also face legal challenges that could delay or disrupt implementation.
...

Press Coverage 2 results